Ameriprise Financial Inc Ligand Pharmaceuticals Inc Transaction History

Ameriprise Financial Inc

  • $364 Billion
  • Q2 2024

A detailed history of Ameriprise Financial Inc transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Ameriprise Financial Inc holds 100,041 shares of LGND stock, worth $11.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100,041
Previous 116,293 13.98%
Holding current value
$11.3 Million
Previous $8.5 Million 0.85%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$68.53 - $87.91 $1.11 Million - $1.43 Million
-16,252 Reduced 13.98%
100,041 $8.43 Million
Q1 2024

May 15, 2024
BUY
$68.64 - $89.2 $667,043 - $866,845
9,718 Added 9.12%
116,293 $8.5 Million
Q4 2023

Feb 14, 2024
SELL
$49.57 - $72.63 $1.43 Million - $2.1 Million
-28,868 Reduced 21.31%
106,575 $7.61 Million
Q3 2023

Nov 14, 2023
SELL
$58.86 - $72.67 $626,917 - $774,008
-10,651 Reduced 7.29%
135,443 $8.12 Million
Q2 2023

Aug 14, 2023
BUY
$69.53 - $79.33 $943,243 - $1.08 Million
13,566 Added 10.24%
146,094 $10.5 Million
Q1 2023

May 15, 2023
SELL
$65.67 - $77.08 $167,392 - $196,476
-2,549 Reduced 1.89%
132,528 $9.75 Million
Q4 2022

Feb 14, 2023
SELL
$61.72 - $96.74 $551,529 - $864,468
-8,936 Reduced 6.2%
135,077 $9.02 Million
Q3 2022

Nov 14, 2022
SELL
$0.01 - $107.56 $61 - $658,159
-6,119 Reduced 4.08%
144,013 $12.4 Million
Q2 2022

Aug 15, 2022
BUY
$74.52 - $117.06 $2.89 Million - $4.54 Million
38,784 Added 34.83%
150,132 $13.4 Million
Q1 2022

May 16, 2022
SELL
$94.99 - $151.56 $66,682 - $106,395
-702 Reduced 0.63%
111,348 $12.5 Million
Q4 2021

Feb 14, 2022
BUY
$127.69 - $165.85 $169,061 - $219,585
1,324 Added 1.2%
112,050 $17.3 Million
Q3 2021

Nov 15, 2021
BUY
$102.33 - $144.73 $2 Million - $2.84 Million
19,590 Added 21.5%
110,726 $15.4 Million
Q2 2021

Aug 16, 2021
SELL
$113.03 - $155.64 $115,516 - $159,064
-1,022 Reduced 1.11%
91,136 $12 Million
Q1 2021

May 17, 2021
SELL
$99.52 - $215.83 $7.56 Million - $16.4 Million
-76,011 Reduced 45.2%
92,158 $14.1 Million
Q4 2020

Feb 12, 2021
SELL
$80.55 - $106.05 $3.08 Million - $4.05 Million
-38,185 Reduced 18.5%
168,169 $16.7 Million
Q3 2020

Nov 16, 2020
SELL
$89.56 - $126.72 $22.4 Million - $31.7 Million
-250,272 Reduced 54.81%
206,354 $19.7 Million
Q2 2020

Aug 14, 2020
BUY
$68.28 - $123.65 $8.55 Million - $15.5 Million
125,265 Added 37.8%
456,626 $51.1 Million
Q1 2020

May 15, 2020
BUY
$63.37 - $107.88 $1.48 Million - $2.52 Million
23,327 Added 7.57%
331,361 $24.1 Million
Q4 2019

Feb 14, 2020
SELL
$96.94 - $113.59 $2.32 Million - $2.72 Million
-23,938 Reduced 7.21%
308,034 $32.1 Million
Q3 2019

Nov 14, 2019
BUY
$86.25 - $120.16 $1.69 Million - $2.36 Million
19,629 Added 6.28%
331,972 $33 Million
Q2 2019

Aug 14, 2019
SELL
$107.38 - $129.34 $1.96 Million - $2.37 Million
-18,297 Reduced 5.53%
312,343 $35.6 Million
Q1 2019

May 15, 2019
SELL
$105.93 - $142.47 $37.6 Million - $50.6 Million
-355,358 Reduced 51.8%
330,640 $41.6 Million
Q4 2018

Feb 14, 2019
BUY
$128.36 - $272.13 $5.35 Million - $11.3 Million
41,686 Added 6.47%
685,998 $93.1 Million
Q3 2018

Nov 14, 2018
SELL
$211.18 - $274.49 $25.5 Million - $33.2 Million
-120,857 Reduced 15.79%
644,312 $177 Million
Q2 2018

Aug 14, 2018
SELL
$150.77 - $207.98 $1.1 Million - $1.52 Million
-7,325 Reduced 0.95%
765,169 $159 Million
Q1 2018

May 15, 2018
BUY
$138.63 - $182.62 $50.6 Million - $66.7 Million
365,122 Added 89.63%
772,494 $128 Million
Q4 2017

Feb 12, 2018
BUY
$128.36 - $147.04 $3.01 Million - $3.45 Million
23,453 Added 6.11%
407,372 $55.8 Million
Q3 2017

Nov 07, 2017
BUY
$120.91 - $137.94 $46.4 Million - $53 Million
383,919
383,919 $52.3 Million

Others Institutions Holding LGND

# of Institutions
249
Shares Held
17.7M
Call Options Held
61K
Put Options Held
7.8K
View Full List

About LIGAND PHARMACEUTICALS INC

LGND Quotes by TradingView
  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $1.91B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email